Nucleic acids and proteins with growth hormone activity

Details Nucleic acids and proteins with growth hormone activity Nucleic acids and proteins with growth hormone activity

2005-09-20

2005-09-20

Chernyshev, Olga N. (Department: 1646)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S069100, C435S320100, C424S198100, C530S350000, C530S399000, C536S023510, C536S023100, C536S023500, C514S012200

Reexamination Certificate

active

06946265

ABSTRACT:
The invention relates to novel growth hormone activity (GHA) proteins and nucleic acids. The invention further relates to the use of the GHA proteins in the treatment of growth hormone related disorders.

REFERENCES:
patent: 4658021 (1987-04-01), Goeddel et al.
patent: 4665160 (1987-05-01), Seeburg
patent: 5068317 (1991-11-01), Becker et al.
patent: 5079345 (1992-01-01), Becker et al.
patent: 5424199 (1995-06-01), Goeddel et al.
patent: 5506107 (1996-04-01), Cunningham et al.
patent: 5534617 (1996-07-01), Cunningham et al.
patent: 5580723 (1996-12-01), Wells et al.
patent: 5597709 (1997-01-01), Rosen et al.
patent: 5612315 (1997-03-01), Pikal et al.
patent: 5633352 (1997-05-01), Dalbøge et al.
patent: 5635604 (1997-06-01), Dalbøge et al.
patent: 5688666 (1997-11-01), Bass et al.
patent: 6188965 (2001-02-01), Mayo et al.
patent: 6269312 (2001-07-01), Mayo et al.
patent: 6403312 (2002-06-01), Dahiyat et al.
patent: 6708120 (2004-03-01), Mayo et al.
patent: 6780613 (2004-08-01), Wells et al.
patent: 2001/0032052 (2001-10-01), Mayo et al.
patent: 2001/0039480 (2001-11-01), Mayo et al.
patent: 2002/0004706 (2002-01-01), Mayo et al.
patent: 2002/0048772 (2002-04-01), Dahiyat et al.
patent: 2002/0090648 (2002-07-01), Dahiyat et al.
patent: 2002/0106694 (2002-08-01), Mayo et al.
patent: 2003/0049654 (2003-03-01), Dahiyat et al.
patent: 2003/0130827 (2003-07-01), Bentzien et al.
patent: 2004/0043429 (2004-03-01), Dahiyat et al.
patent: 2004/0043430 (2004-03-01), Dahiyat et al.
patent: 0 974 111 (2000-01-01), None
patent: 97/11178 (1997-03-01), None
patent: 98/47089 (1998-10-01), None
patent: WO 00/23564 (2000-04-01), None
patent: WO 01/59066 (2001-08-01), None
patent: WO 01/59066 (2001-08-01), None
patent: WO 03/014325 (2003-02-01), None
patent: WO 03/014325 (2003-02-01), None
Nicoll et al., 1986, Endocrine Reviews, vol. 7, No. 2, pp. 169-203.
Cunningham et al., 1991, Proc.Natl.Acad.Sci,USA, vol. 88, pp. 3407-3411.
Lowman and Wells, “Affinity Maturation of Human Growth Hormone by Monovalent Phage Disply”J. Mol. Biol. 234:564-578 (1993).
U.S. Appl. No. 09/127,926, filed Jul. 7, 1998, Mayo et al.
Nicoll et al., “Structural Features of Prolactins and Growth Hormones That Can be Related to Their Biological Properties”,Endocr. Rev. 7(2):169-203 (1986).
Chawla et al., “Structural Variants of Human Growth Hormone: Biochemical, Genetic, and Clinical Aspects”,Annu. Rev. Med. 34:519-547 (1983).
Edwards, et al., “A Newly Defined Property of Somatotropin: Priming of Macrophages for Production of Superoxide Anion”,Science238(4841 Pt1):769-771 (1988).
Thorner and Vance, “Growth Hormone, 1988”,J. Clin. Invest. 82(3):745-747 (1988).
Leung, et al., “Growth hormone receptor and serum binding protein: purification, cloning and expression”,Nature330(6148):537-543 (1987).
Boutin et al., “Cloning and Expression of the Rat Prolactin Receptor, a Member of the Growth Hormone/Prolactin Receptor Gene Family”,Cell53(1):69-77 (1988).
Finidori, “Regulators of Growth Hormone Signaling”,Vitam. Horm. 59:71-97 (2000).
Carter-Su et al., “Signalling Pathway of GH”,Endocr. J. 43 Suppl:S65-70 (1996).
Campbell, “Growth-hormone signal transduction”,J. Piediatr. 131(1 Pt2):S42-44 (1997).
Ramaswami et al., “Growth hormone therapy in hypochondroplasia”,Acta. Paediatr. Suppl. 88(428):116-117 (1999).
Kamp and Wit, “High-Dose Growth Hormone Therapy in Idiopathic Short Stature”,Horm. Res. 49(suppl. 2):67-72 (1998).
de Meuinck Keizer-Schrama et al., “Growth hormone treatment regimens in girls with Turner syndrome”,Acta. Paediatr. Suppl. 88(433):126-129 (1999).
Hauesler, “Growth Hormone Therapy in Patients with Turner Syndrome”,Horm. Res. 49(Suppl. 2):62-66 (1998).
Low et al., “Effect of growth hormone on growth delay in burned children: a 3-year follow-up study”,Lancet354(9192):1789 (1999).
Herndon et al., “Growth Hormone Treatment for Burned Children”,Horm. Res. 45(Suppl. 1):29-31 (1996).
Bengtsson et al., “The Treatment of Growth Hormone Deficiency in Adults”,J. Clin. Encodrinol. Metab. 85(3):933-942 (2000).
Cook et al., “The Adult Growth Hormone Deficiency Syndrome”,Adv. Intern. Med. 45:297-315 (2000).
Welle, “Growth hormone and insulin-like growth factor-I as anabolic agents”,Curr. Opin. Clin. Nutr. Metab. Care1(3):257-262 (1998).
Abs, et al., “GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety”,Clinical Endocrinology50:703-713 (1999).
Clark and Kendall, “Growth hormone treatment for growth hormone deficient adults”,J. Clin. Pharm. Ther. 21:367-372 (1996).
Windisch et al., “Recombinant Human Growth Hormone for AIDS-Associated Wasting”,Ann. Pharmacother. 32(4):437-445 (1998).
Menster et al, “Growth-hormone treatment of renal transplant recipients: The National Cooperative Growth Study experience—A report of the National Cooperative Growth Study and the North American Pediatric Renal Transplant Cooperative Study”,J. Pediatr. 131(1 Pt2):S20-24 (1997).
Hirschfeld, “Use of Human Recombinant Growth Hormone and Human Recombinant Insulin-Like Growth Factor-I in Patients with Human Immunodeficiency Virus Infection”,Horm. Res. 46:215-221 (1996).
Cittadini et al., “Growth Hormone and the Heart”,Miner. Electrolyte Metab. 25:51-55 (1999).
Johnson and Gheorghiade, “Growth hormone therapy in patients with congestive heart failure: Need for further research”,Am. Heart J. 137(6):989-991 (1999).
Sacca, “Growth hormone: a new therapy for heart failure?”,Bailliere's Clin. Endocrinol. Metab. 12(2):217-231 (1998).
Gomberg-Maitland and Frishman, “Recombinant growth hormone: A new cardiovascular drug therapy”,Am. Heart J. 132(6):1244-1262 (1996).
Tanaka, “Growth Hormone and Bone Disease”,Endocr. J. 45(Suppl):S47-52 (1998).
Reginster et al., “Promising New Agents in Osteoporosis”,Drugs R.D. 1(3):195-201 (1999).
Sharara and Giudice, “Role of Growth Hormone in Ovarian Physiiology and Onset of Puberty”,J. Soc. Gynecol. Investig. 4(1):2-7 (1997).
Artini et al., “Growth hormone cotreatment with gonadotropins in ovulation induction”,J. Endocrinol. Invest. 19:763-779 (1996).
Homburg, “Growth Hormone and Fertility—Clinical Studies”,Horm. Res. 45:81-85 (1996).
Homburg and Farhi, “Growth hormone and reproduction”,Curr. Opin. Obstet. Gynecol. 7:220-223 (1995).
Homburg and Ostergaard, “Clinical applications of growth hormone for ovarian stimulation”,Hum. Reprod. Update1(3):264-275 (1995).
Bouillanne et al., “Growth hormone therapy in elderly people: an age-delaying drug?”,Fundam. Clin. Pharmacol. 10:416-430 (1996).
Rasmussen, “Evaluation of recombinant human growth hormone for wound management”,Dan. Med. Bull. 42(4):358-370 (1995).
Wennbo and Tornell, “The role of prolactin and growth hormone in breast cancer”,Oncogene19:1072-1076 (2000).
Ritzen, et al., “Growth Hormone Treatment of Patients with Prader-Will Syndrome”,J. Pediatr. Endocrinol. Metabol. 12(Suppl 1):345-349 (1999).
Nagi and Mori, “Prader-Willi syndrome, diabetes mellitus and hypogonadism”,Biomed. Pharmacother. 53:452-454 (1999).
Chappel, “Growth Hormone in Immune Reconstitution,”,J. Acquir. Immune Def. Sundr. Hum. Retrovirol. 20(5):423-431 (1999).
Scacchi et al., “Growth hormone in obesity”,Int. J. Obes. 23:260-271 (1999).
Stanhope et al., “Growth hormone Treatment of Russell-Silver Syndrome”,Horm. Res. 49(Suppl. 2):37-40 (1998).
Tritos and Mantzoros, “Recombinant Human Growth Hormone: Old and Novel Uses”,Am. J. Med. 105:44-57 (1998).
Vance, “The Gordon Wilson Lecture—Growth Hormone

Affiliated with

Also associated with

Rating

Nucleic acids and proteins with growth hormone activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acids and proteins with growth hormone activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids and proteins with growth hormone activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3410103